Monday, September 22, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Arcosa Inc Acquires Ameron Pole Products Expanding Market Presence and Product Offerings

Elaine Mendonca by Elaine Mendonca
March 11, 2024
in Breaking News
0
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

On March 11, 2024, Arcosa Inc announced a significant milestone with the finalization of a $180 million acquisition deal for Ameron Pole Products from NOV Inc.

Ameron, a company with a rich history dating back to 1970, is renowned for its premium concrete and steel poles used in various infrastructure applications. With four manufacturing facilities strategically located, Ameron has built a strong reputation in the industry.

This acquisition marks a strategic move for Arcosa, as it will not only expand their market presence but also enhance their product offerings in key sectors such as lighting, traffic, electric distribution, and small-cell telecom.

The transaction is scheduled to be completed in the second quarter of 2024, with Arcosa planning to finance the purchase through a combination of cash and available credit facilities.

Antonio Carrillo, President and CEO of Arcosa, expressed excitement about the acquisition, emphasizing that it will allow the company to enter the steel and concrete lighting pole market while strengthening their position in the traffic and telecom sectors.

ACA Stock Price Update: March 11, 2024 – Analysis and Forecast

On March 11, 2024, ACA stock experienced a slight decrease in its price, dropping by $0.74 or 0.87% since the market last closed. Despite this decrease, ACA is still trading near the top of its 52-week range and above its 200-day simple moving average, indicating a strong performance overall. The stock opened at $84.77, which was $0.05 higher than its previous close. This slight increase in the opening price may have initially indicated positive momentum for the stock. However, as the day progressed, the price of ACA shares dropped, resulting in the overall decrease by the market close. Investors and analysts may be closely monitoring ACA’s performance to determine if this slight dip is a temporary fluctuation or if it signals a longer-term trend. Factors such as market conditions, company news, and industry trends could all impact ACA’s stock performance in the coming days and weeks. It is important for investors to conduct thorough research and analysis before making any investment decisions, especially in a volatile market environment. Keeping an eye on key indicators such as price momentum, moving averages, and trading ranges can help investors make informed choices about their investment portfolios.

ACA Stock Performance Analysis: Flat Revenue and Decrease in Net Income Raise Investor Concerns

On March 11, 2024, ACA stock experienced a mixed performance based on the financial data provided by CNN Money. The company reported a total revenue of $2.31 billion for the past year, which remained flat compared to the previous year. However, the total revenue for the fourth quarter was $582.20 million, also holding flat since the last quarter. In terms of net income, ACA reported a net income of $158.60 million for the past year, showing a decrease of 35.21% compared to the previous year. The net income for the fourth quarter was $27.00 million, reflecting a decrease of 23.73% since the last quarter. Earnings per share (EPS) for ACA stock were reported at $3.26 for the past year, marking a decrease of 35.48% compared to the previous year. The EPS for the fourth quarter was $0.55, holding flat since the last quarter. Overall, ACA stock’s performance on March 11, 2024, was impacted by the decrease in net income and EPS compared to the previous year. Investors may have concerns about the company’s profitability and growth potential. It will be important for ACA to address these issues and implement strategies to improve its financial performance in order to regain investor confidence and drive stock value in the future.

Tags: ACA
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Unraveling the Potential of AI in Tailoring Healthcare Solutions

Challenges Faced by EU Gig Worker Rights Directive

Finance_Assets (3)

Financial Analyst Maintains Hold Rating for JDcom with Raised Price Target

Investor Sentiment and Options Trading Activity for Pfizer

Recommended

IBM Stock

IBM’s Market Conundrum: Strong Fundamentals Clash With Share Price Decline

1 week ago
Red Cat Stock

Red Cat’s Naval Ambitions Meet Investor Skepticism

4 weeks ago
COST stock news

Versus Systems Inc Meets Nasdaqs Minimum Bid Price Requirement

2 years ago
Super Micro Computer Stock

Strategic Nokia Alliance Offers Super Micro a Path Through Governance Challenges

2 weeks ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

AAPL Adobe Alibaba Alphabet Amazon AMD AMZN Apple ASML BA BigBear.ai BioNTech Broadcom Coinbase Eli Lilly Fiserv Hims & Hers IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Opendoor Oracle Oxford Lane Capital Palantir PayPal Pepsi Red Cat Robinhood Rocket Lab USA Salesforce Strategy Tesla TSLA Unitedhealth Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Insider Sales at Tutor Perini Coincide with Stock Peak

Ubiquiti Shares Reach New Heights on Product Expansion Momentum

BioNTech’s Strategic Pivot: From Pandemic Success to Oncology Innovation

Leadership Crisis at Nestlé Sparks Investor Concerns

Standex Shares Plunge Amid Technical Warnings and Insider Selling

Navigating Credit Headwinds: Synchrony’s Strategic Expansion Amid Sector Challenges

Trending

Dynex Capital Stock
Analysis

Dynex Capital’s Dividend Sustainability Questioned Amid Massive Payout Ratio

by Felix Baarz
September 22, 2025
0

A major institutional investor has dramatically increased its stake in mortgage REIT Dynex Capital, even as fundamental...

Pfizer Stock

Pfizer’s Strategic Gambit: A $7.3 Billion Entry into the Weight-Loss Arena

September 22, 2025
Nike Stock

Nike Shares Face Critical Earnings Test

September 22, 2025
Tutor Perini Stock

Insider Sales at Tutor Perini Coincide with Stock Peak

September 22, 2025
Ubiquiti Stock

Ubiquiti Shares Reach New Heights on Product Expansion Momentum

September 22, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Dynex Capital’s Dividend Sustainability Questioned Amid Massive Payout Ratio
  • Pfizer’s Strategic Gambit: A $7.3 Billion Entry into the Weight-Loss Arena
  • Nike Shares Face Critical Earnings Test

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com